Eric Dutang Appointed as CFO at biolog-id
In alignment with its strategic plan for growth and readiness for going public, biolog-id, a global leader in the traceability of sensitive therapeutic products, reinforces its executive team by appointing
Stay updated with breaking news from Eric Dutang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In alignment with its strategic plan for growth and readiness for going public, biolog-id, a global leader in the traceability of sensitive therapeutic products, reinforces its executive team by appointing
CLLS earnings call for the period ending August 6, 2021.
Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Cellectis SA (NASDAQ: CLLS) Operator Greetings. Welcome to the Cellectis Fourth Quarter and Full-Year 2020 Earnings Call. At this time, all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. At this time, I'll turn the conference over to Simon Harnest, Chief Investment Officer. Simon, you may begin. This article...